Volume 17, Number 4,
Issue of February 15, 1997
pp. 1505-1511
Copyright ©1997 Society for Neuroscience
A Five Minute Experience in the Elevated Plus-Maze Alters the
State of the Benzodiazepine Receptor in the Dorsal Raphe Nucleus
Received Oct. 3, 1996; revised Nov. 27, 1996; accepted Dec. 2, 1996.
Luis E. Gonzalez and
Sandra E. File
Psychopharmacology Research Unit, UMDS Division of Pharmacology,
Guy's Hospital, London SE1 9RT, United Kingdom
A single 5 min exposure to the elevated plus-maze test of anxiety
renders animals insensitive to the anxiolytic effects of the
benzodiazepines in this test. The purpose of the present experiments was to explore whether this phenomenon resulted from a change in the
functional state of benzodiazepine receptors in the dorsal raphe
nucleus. The benzodiazepine receptor agonist midazolam (0.5, 1, and 2 µg) and antagonist flumazenil (100 and 500 ng) were directly administered to the dorsal raphe nucleus in rats either naive to, or
with one previous 5 min exposure of, the elevated plus-maze. In naive
rats, midazolam produced significant anxiolytic effects at all doses,
and flumazenil was silent. In plus-maze-experienced rats, midazolam no
longer had anxiolytic effects in the plus-maze, but flumazenil did,
indicating that the previous experience of the maze had changed the
state of the benzodiazepine receptor. This changed receptor function
generalized to the social interaction test. Thus, in naive animals
tested in high light, midazolam (0.5, 1, and 2 µg) had significant
anxiolytic effects and flumazenil (100 and 500 ng) was silent, whereas
in plus-maze-experienced rats both midazolam (1 µg) and flumazenil
(500 ng) had significant anxiolytic effects. Extensive analysis of
locomotor activity in both tests showed that the changed responsivity
to midazolam could not be explained by habituation, because on none of
the measures used was there any difference in motor activity scores
between plus-maze-naive and experienced rats.
Key words:
benzodiazepine receptors;
dorsal raphe;
midazolam;
flumazenil;
plus-maze;
social interaction